Testing the Cre-mediated genetic switch for the generation of conditional knock-in mice.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 29 09 2018
accepted: 25 02 2019
entrez: 14 3 2019
pubmed: 14 3 2019
medline: 24 12 2019
Statut: epublish

Résumé

The Cre-mediated genetic switch combines the ability of Cre recombinase to stably invert or excise a DNA fragment depending upon the orientation of flanking mutant loxP sites. In this work, we have tested this strategy in vivo with the aim to generate two conditional knock-in mice for missense mutations in the Impad1 and Clcn7 genes causing two different skeletal dysplasias. Targeting constructs were generated in which the Impad1 exon 2 and an inverted exon 2* and the Clcn7 exon 7 and an inverted exon 7* containing the point mutations were flanked by mutant loxP sites in a head-to-head orientation. When the Cre recombinase is present, the DNA flanked by the mutant loxP sites is expected to be stably inverted leading to the activation of the mutated exon. The targeting vectors were used to generate heterozygous floxed mice in which inversion of the wild-type with the mutant exon has not occurred yet. To generate knock-in mice, floxed animals were mated to a global Cre-deleter mouse strain for stable inversion and activation of the mutation. Unexpectedly the phenotype of homozygous Impad1 knock-in animals overlaps with the lethal phenotype described previously in Impad1 knock-out mice. Similarly, the phenotype of homozygous Clcn7 floxed mice overlaps with Clcn7 knock-out mice. Expression studies by qPCR and RT-PCR demonstrated that mutant mRNA underwent abnormal splicing leading to the synthesis of non-functional proteins. Thus, the skeletal phenotypes in both murine strains were not caused by the missense mutations, but by aberrant splicing. Our data demonstrate that the Cre mediated genetic switch strategy should be considered cautiously for the generation of conditional knock-in mice.

Identifiants

pubmed: 30865697
doi: 10.1371/journal.pone.0213660
pii: PONE-D-18-28415
pmc: PMC6415906
doi:

Substances chimiques

Cre recombinase EC 2.7.7.-
Integrases EC 2.7.7.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0213660

Déclaration de conflit d'intérêts

M. Capulli, R. Costantini, A. Maurizi, C. Paganini, L. Monti, A. Forlino, A. Teti, A. Rossi do not report disclosures. S. Sonntag and D. Shmerling are affiliated to PolyGene AG. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.

Références

Nature. 2008 Jun 5;453(7196):788-92
pubmed: 18449189
Am J Hum Genet. 2011 May 13;88(5):608-15
pubmed: 21549340
Am J Med Genet A. 2015 Dec;167A(12):2869-92
pubmed: 26394607
Transgenic Res. 2007 Aug;16(4):405-13
pubmed: 17415672
Regen Med. 2008 Mar;3(2):217-35
pubmed: 18307405
Bone. 2014 Feb;59:66-75
pubmed: 24185277
J Bone Miner Res. 2018 Aug;33(8):1489-1499
pubmed: 29665086
J Pathol. 2011 Jun;224(2):160-8
pubmed: 21506131
Cell. 2001 Jan 26;104(2):205-15
pubmed: 11207362
Nucleic Acids Res. 2002 Sep 1;30(17):e90
pubmed: 12202778
Nat Rev Genet. 2005 Jun;6(6):507-12
pubmed: 15931173
Hum Mol Genet. 2016 Oct 1;25(R2):R86-R93
pubmed: 27346519
Mamm Genome. 2012 Oct;23(9-10):580-6
pubmed: 22968824
Nat Biotechnol. 2003 May;21(5):562-5
pubmed: 12665802
Hum Mol Genet. 2005 Mar 15;14(6):859-71
pubmed: 15703192
Hum Mol Genet. 2015 Oct 1;24(19):5570-80
pubmed: 26206888
Clin Perinatol. 2015 Jun;42(2):301-19, viii
pubmed: 26042906
Mamm Genome. 2017 Aug;28(7-8):291-301
pubmed: 28677007
Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11605-12
pubmed: 18695242
Hum Mol Genet. 2017 Aug 1;26(15):2897-2911
pubmed: 28475764
BMC Biotechnol. 2010 Mar 31;10:29
pubmed: 20356367
J Bone Miner Res. 2010 Jul;25(7):1468-86
pubmed: 20533309
Development. 2008 Jul;135(13):2215-20
pubmed: 18539921
Mol Ther Nucleic Acids. 2015 Sep 01;4:e248
pubmed: 26325626
Methods Mol Biol. 2000;137:491-8
pubmed: 10948562
J Bone Miner Res. 2003 Aug;18(8):1513-8
pubmed: 12929941
Physiol Genomics. 2002 Dec 3;11(3):115-32
pubmed: 12464688

Auteurs

Mattia Capulli (M)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Rossella Costantini (R)

Department of Molecular Medicine, Unit of Biochemistry, University of Pavia, Pavia, Italy.

Stephan Sonntag (S)

PolyGene AG, Rümlang, Switzerland.
ETH Phenomics Center (EPIC), ETH Zürich, Zürich, Switzerland.

Antonio Maurizi (A)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Chiara Paganini (C)

Department of Molecular Medicine, Unit of Biochemistry, University of Pavia, Pavia, Italy.
Scuola Universitaria Superiore IUSS, Pavia, Italy.

Luca Monti (L)

Department of Molecular Medicine, Unit of Biochemistry, University of Pavia, Pavia, Italy.

Antonella Forlino (A)

Department of Molecular Medicine, Unit of Biochemistry, University of Pavia, Pavia, Italy.

Doron Shmerling (D)

PolyGene AG, Rümlang, Switzerland.

Anna Teti (A)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Antonio Rossi (A)

Department of Molecular Medicine, Unit of Biochemistry, University of Pavia, Pavia, Italy.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH